![Alison V. Todd](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alison V. Todd active positions
Companies | Position | Start | End |
---|---|---|---|
SpeeDx Pty Ltd.
![]() SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Chief Tech/Sci/R&D Officer | 07/06/2011 | - |
Founder | 07/06/2011 | - |
Career history of Alison V. Todd
Former positions of Alison V. Todd
Companies | Position | Start | End |
---|---|---|---|
Johnson & Johnson Research Pty Ltd. | Chief Tech/Sci/R&D Officer | - | - |
Training of Alison V. Todd
The University of Sydney | Doctorate Degree |
Statistics
International
Australia | 3 |
Japan | 2 |
Operational
Chief Tech/Sci/R&D Officer | 2 |
Founder | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
SpeeDx Pty Ltd.
![]() SpeeDx Pty Ltd. BiotechnologyHealth Technology SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia. | Health Technology |
Johnson & Johnson Research Pty Ltd. |
- Stock Market
- Insiders
- Alison V. Todd
- Experience